CEBPA and acute myeloid leukemia: Sporadic mutations in CEBPA (monoallelic or biallelic) have been reported 5–14% of individuals with AML (32, 33), and among those whose leukemias have biallelic mutations, germline CEBPA mutations were found in about 11.1% of patients (33).